Lancet[journal] 检索结果

61. The clinical effectiveness of clarithromycin versus endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps (MACRO): a pragmatic, multicentre, three-arm, randomised, placebo-controlled phase 4 trial.

作者: Carl Philpott.;David J Beard.;Elnaz Saeedi.;Jonathan A Cook.;Stephen Jones.;Caroline S Clarke.;Lucinda Teoh.;Mike Thomas.;Paul Little.;Jane Vennik.;Valerie Lund.;Anne G M Schilder.;Fei Long.;Stephen Durham.;James Boardman.;Claire Hopkins.; .; .
来源: Lancet. 2025年406卷10506期926-939页

A paucity of evidence regarding use of endoscopic sinus surgery and antibiotics in managing chronic rhinosinusitis has contributed to a five-times variation in endoscopic sinus surgery rates, as well as variation in the use of antibiotics. The main aim of the present trial was to compare the clinical effectiveness of endoscopic sinus surgery or 3 months of clarithromycin treatment alongside intranasal medication in adults with chronic rhinosinusitis with or without nasal polyps.

62. Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials.

作者: Nelson Wang.;Abdul Salam.;Rashmi Pant.;Amit Kumar.;Rupasvi Dhurjati.;Faraidoon Haghdoost.;Kota Vidyasagar.;Prachi Kaistha.;Hariprasad Esam.;Sonali R Gnanenthiran.;Raju Kanukula.;Paul K Whelton.;Brent Egan.;Aletta E Schutte.;Kazem Rahimi.;Otavio Berwanger.;Anthony Rodgers.
来源: Lancet. 2025年406卷10506期915-925页

We aimed to quantify the blood pressure-lowering efficacy of antihypertensive drugs and their combinations from the five major drug classes.

63. Estimating the benefits of personalised glycaemic control - Authors' reply.

作者: Pedro Cardoso.;Trevelyan J McKinley.;Angus G Jones.;Andrew T Hattersley.;John M Dennis.
来源: Lancet. 2025年406卷10506期914页

64. Estimating the benefits of personalised glycaemic control.

作者: David van Klaveren.;Patrick W Serruys.;David M Kent.
来源: Lancet. 2025年406卷10506期913-914页

65. Hidradenitis suppurativa: complexity in pathogenesis and management - Authors' reply.

作者: Robert Sabat.;Afsaneh Alavi.;Kerstin Wolk.;Amit Garg.
来源: Lancet. 2025年406卷10506期912-913页

66. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Shauna R Campbell.;Rashmi Unwala.;Chirag Shah.
来源: Lancet. 2025年406卷10506期911-912页

67. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Claude Bachmeyer.
来源: Lancet. 2025年406卷10506期911页

68. The Lancet Countdown Report: missing links in climate action - Authors' reply.

作者: Ollie Jay.;Ian Hamilton.;Marina Romanello.
来源: Lancet. 2025年406卷10506期910页

69. Hidradenitis suppurativa: complexity in pathogenesis and management.

作者: Jieying Tang.;Xiaoyin Bai.
来源: Lancet. 2025年406卷10506期910-911页

70. The Lancet Countdown Report: missing links in climate action.

作者: Tormod Rogne.;Kai Chen.;Jeanette H Magnus.
来源: Lancet. 2025年406卷10506期909页

71. The Lancet Countdown Report: missing links in climate action.

作者: Jie-Yu Chuang.
来源: Lancet. 2025年406卷10506期909-910页

72. Why are we failing to rapidly diagnose tuberculosis in the UK?

作者: Francis Drobniewski.;Onn Min Kon.;Ximena Gonzalo.;Marcia Ashmi.
来源: Lancet. 2025年406卷10506期908-909页

73. Using big picture trends for global health.

作者: Tim Colbourn.
来源: Lancet. 2025年406卷10506期890-891页

74. Endoscopic sinus surgery versus macrolides in chronic rhinosinusitis: redefining clinical priorities.

作者: Zhenxiao Huang.;Bing Zhou.
来源: Lancet. 2025年406卷10506期887-889页

75. Better blood pressure control with predictable drug dosing.

作者: Mattias Brunström.;Reinhold Kreutz.
来源: Lancet. 2025年406卷10506期886-887页

76. The dialogue around NCDs needs to change.

作者: The Lancet.
来源: Lancet. 2025年406卷10506期885页

77. Resident doctor strikes in the UK: a lived reality.

作者: Sruthi Saravanan.
来源: Lancet. 2025年406卷10506期907-908页

78. Upholding medical ethics: a letter to the Israeli Medical Association.

作者: Leon Geffen.;Mitch Besser.;Eric Goemaere.;Glenda Gray.;Peter Lloyd Sherlock.;Shabir Madhi.;Shuaib Manjra.;Max Price.;Francois Venter.
来源: Lancet. 2025年406卷10506期907页

79. Tackling cardiovascular disease in the Asia-Pacific region: a new Lancet Commission.

作者: Carolyn S P Lam.;F Aaysha Cader.;Nicholas W S Chew.;Clara K Chow.;Corina Grey.;Yuming Guo.;Adam J Nelson.;Anna Rolleston.;Mitsuaki Sawano.;Kathryn Choon Beng Tan.;Jasper Tromp.;Lijing L Yan.;Stephen J Nicholls.
来源: Lancet. 2025年406卷10507期988-989页

80. Iran and beyond: perilous threats to population health.

作者: Maziar Moradi-Lakeh.;Reza Majdzadeh.;Mohammad Reza Farzanegan.;Mohsen Naghavi.
来源: Lancet. 2025年406卷10507期1001-1002页

结果排序

文献格式

出版时间

出版类型

出版语言